chrX-154414113-T-C

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_001440856.1(TAFAZZIN):​c.437T>C​(p.Phe146Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,204,023 control chromosomes in the GnomAD database, including 64 homozygotes. There are 925 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 28 hom., 414 hem., cov: 23)
Exomes 𝑓: 0.0017 ( 36 hom. 511 hem. )

Consequence

TAFAZZIN
NM_001440856.1 missense

Scores

6
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 0.303

Publications

7 publications found
Variant links:
Genes affected
TAFAZZIN (HGNC:11577): (tafazzin, phospholipid-lysophospholipid transacylase) This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]
TAFAZZIN Gene-Disease associations (from GenCC):
  • Barth syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 7 uncertain in NM_001440856.1
BP4
Computational evidence support a benign effect (MetaRNN=0.0038991868).
BP6
Variant X-154414113-T-C is Benign according to our data. Variant chrX-154414113-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 42259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0538 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001440856.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAFAZZIN
NM_000116.5
MANE Select
c.383T>Cp.Phe128Ser
missense
Exon 5 of 11NP_000107.1
TAFAZZIN
NM_001440856.1
c.437T>Cp.Phe146Ser
missense
Exon 5 of 11NP_001427785.1
TAFAZZIN
NM_001303465.2
c.437T>Cp.Phe146Ser
missense
Exon 5 of 10NP_001290394.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAFAZZIN
ENST00000601016.6
TSL:1 MANE Select
c.383T>Cp.Phe128Ser
missense
Exon 5 of 11ENSP00000469981.1
TAFAZZIN
ENST00000475699.6
TSL:1
c.424+546T>C
intron
N/AENSP00000419854.3
TAFAZZIN
ENST00000369776.8
TSL:1
c.295+546T>C
intron
N/AENSP00000358791.4

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
1786
AN:
110076
Hom.:
28
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0563
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00554
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000152
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.00457
AC:
831
AN:
182022
AF XY:
0.00275
show subpopulations
Gnomad AFR exome
AF:
0.0568
Gnomad AMR exome
AF:
0.00245
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000160
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00172
AC:
1881
AN:
1093889
Hom.:
36
Cov.:
29
AF XY:
0.00142
AC XY:
511
AN XY:
359485
show subpopulations
African (AFR)
AF:
0.0592
AC:
1559
AN:
26317
American (AMR)
AF:
0.00284
AC:
100
AN:
35177
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19346
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30175
South Asian (SAS)
AF:
0.0000556
AC:
3
AN:
53923
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.00222
AC:
9
AN:
4049
European-Non Finnish (NFE)
AF:
0.0000549
AC:
46
AN:
838477
Other (OTH)
AF:
0.00357
AC:
164
AN:
45939
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
63
127
190
254
317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0162
AC:
1783
AN:
110134
Hom.:
28
Cov.:
23
AF XY:
0.0128
AC XY:
414
AN XY:
32400
show subpopulations
African (AFR)
AF:
0.0561
AC:
1692
AN:
30181
American (AMR)
AF:
0.00553
AC:
57
AN:
10309
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2625
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3491
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2548
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5878
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000152
AC:
8
AN:
52724
Other (OTH)
AF:
0.0175
AC:
26
AN:
1487
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
65
129
194
258
323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00344
Hom.:
38
Bravo
AF:
0.0191
ESP6500AA
AF:
0.0524
AC:
201
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00535
AC:
650

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
5
not specified (5)
-
-
3
3-Methylglutaconic aciduria type 2 (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Endocardial fibroelastosis (1)
-
-
1
Left ventricular noncompaction cardiomyopathy (1)
-
-
1
Primary dilated cardiomyopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
6.1
DANN
Benign
0.88
DEOGEN2
Benign
0.31
T
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.35
T
MetaRNN
Benign
0.0039
T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Benign
1.6
L
PhyloP100
0.30
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.8
D
REVEL
Uncertain
0.34
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.045
D
Polyphen
0.0
B
Vest4
0.29
MVP
0.68
ClinPred
0.0088
T
GERP RS
-0.54
Varity_R
0.13
gMVP
0.95
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146934311; hg19: chrX-153642450; API